BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11908998)

  • 21. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
    Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
    Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.
    Boer K; de Wit LE; Peters FS; Hesselink DA; Hofland LJ; Betjes MG; Looman CW; Baan CC
    Clin Epigenetics; 2016; 8():116. PubMed ID: 27891189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
    Gendzekhadze K; Rivas-Vetencourt P; Montano RF
    Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
    Woodle ES; Alloway RR; Girnita A
    Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell costimulation blockade and organ transplantation: a change of philosophy for transplant immunologists?
    Goldstein DR
    J Immunol; 2011 Mar; 186(5):2691-2. PubMed ID: 21325217
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytokines as predictive biomarkers of alloreactivity.
    Brunet M
    Clin Chim Acta; 2012 Sep; 413(17-18):1354-8. PubMed ID: 22561186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between IL-4 polymorphism and acute rejection of solid organ allograft: a meta-analysis.
    Wu W; Liu Y; Li S; Hu L; Sun X; Cai L; Gong G
    Gene; 2013 Jan; 513(1):14-21. PubMed ID: 23107766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Messengers of tolerance.
    Bontha SV; Fernandez-Piñeros A; Maluf DG; Mas VR
    Hum Immunol; 2018 May; 79(5):362-372. PubMed ID: 29402484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation: tolerance.
    Hutchings A; Thomas JM
    Curr Opin Investig Drugs; 2003 May; 4(5):530-5. PubMed ID: 12833645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection.
    Brunet M; Millán López O; López-Hoyos M
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S21-8. PubMed ID: 26444655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation.
    Manchanda PK; Mittal RD
    Mol Cell Biochem; 2008 Apr; 311(1-2):57-65. PubMed ID: 18165865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients.
    Karimi MH; Hejr S; Geramizadeh B; Nikeghbalian S; Kamali-Sarvestani E; Yaghobi R
    Immunol Invest; 2014; 43(1):69-85. PubMed ID: 24313807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
    Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
    Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of high and low responders to allografts.
    Hutchinson IV; Pravica V; Hajeer A; Sinnott PJ
    Rev Immunogenet; 1999; 1(3):323-33. PubMed ID: 11256423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
    Ekbal NJ; Holt DW; Macphee IA
    Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of donor tumor necrosis factor-alpha and interleukin-10 genotypes on delayed graft function and acute rejection in kidney transplantation.
    Mandegary A; Azmandian J; Soleymani S; Pootari M; Habibzadeh SD; Ebadzadeh MR; Dehghani-Firouzabadi MH
    Iran J Kidney Dis; 2013 Mar; 7(2):135-41. PubMed ID: 23485538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can proliferation signal inhibitor-induced Tregs really reflect transplantation tolerance in clinical solid organ transplantation?
    Li S; Kuang A; Huang R
    Int Rev Immunol; 2009; 28(5):367-75. PubMed ID: 19811315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
    Zheng HX; Burckart GJ; McCurry K; Webber S; Ristich J; Iacono A; Dauber J; McDade K; Grgurich W; Zaldonis D; Pillage G; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 May; 23(5):541-6. PubMed ID: 15135368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation.
    Sankaran D; Asderakis A; Ashraf S; Roberts IS; Short CD; Dyer PA; Sinnott PJ; Hutchinson IV
    Kidney Int; 1999 Jul; 56(1):281-8. PubMed ID: 10411704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis.
    Warlé MC; Metselaar HJ; Hop WC; Tilanus HW
    Liver Transpl; 2005 Jan; 11(1):19-26. PubMed ID: 15690532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.